Explore › Condition › Anterolateral Myocardial Infarction
Condition

Anterolateral Myocardial Infarction

Also known as: Anterolateral Myocardial Infarction Anterolateral Myocardial Infarctions Infarction, Anterolateral Myocardial Infarctions, Anterolateral Myocardial Myocardial Infarction, Anterolateral Myocardial Infarctions, Anterolateral myocardial infarction; aortic stenosis
3 findings 1 paper 3 related entities View in graph →

Related entities

interventions
Triple antithrombotic therapy1
outcomes
Bleeding requiring transfusion1
studys
PMC67175101

Findings (27)

None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →
None
adverse

MI patients with aortic stenosis receiving both DAPT and oral anticoagulant therapy had substantially increased bleeding risk compared to MI patients without AS on DAPT alone, suggesting additive effe

Effect: adverse; HR 2.47; CI: 95% CI 1.56-3.90

Size: HR 2.47 CI: 95% CI 1.56-3.90
PMC6717510
Finding details → · Paper → · Graph →

Papers (1)